Trend in Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology One Year after Mild and Asymptomatic Coronavirus Disease 2019 (COVID-19): Unpacking Potential Bias in Seroprevalence Studies

Christopher R. Bailie, Yeu Yang Tseng, Louise Carolan, Martyn D. Kirk, Suellen Nicholson, Annette Fox, Sheena G. Sullivan

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

A key aim of serosurveillance during the coronavirus disease 2019 (COVID-19) pandemic has been to estimate the prevalence of prior infection, by correcting crude seroprevalence against estimated test performance for polymerase chain reaction (PCR)-confirmed COVID-19. We show that poor generalizability of sensitivity estimates to some target populations may lead to substantial underestimation of case numbers.

Original languageEnglish
Pages (from-to)e357-e360
Number of pages4
JournalClinical Infectious Diseases
Volume75
Issue number1
DOIs
Publication statusPublished - 1 Jul 2022
Externally publishedYes

Keywords

  • antibody
  • COVID-19
  • sensitivity
  • serology
  • surveillance

Cite this